These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3003954

  • 1. One year follow-up study of T-cell subsets and incidence of seropositivity for HTLV-I and HTLV-III antibodies in patients treated "on demand" or sporadically with clotting concentrates.
    Rodeghiero F, Castaman GC, Chisesi T, De Rossi A, Dalla Gassa O, Del Mistro A, Dini E, Castronovo S, Pornaro E, Chieco-Bianchi L.
    Thromb Haemost; 1985 Oct 30; 54(3):665-8. PubMed ID: 3003954
    [Abstract] [Full Text] [Related]

  • 2. [Immunological status of hemophiliacs: study of blood T-lymphocyte populations, serum immunoglobulins, and the prevalence of anti-LAV antibodies].
    Aymard JP, Janot C, Briquel ME, André E, Schooneman F, Vigneron C, Legras B, Alexandre P, Streiff F.
    Pathol Biol (Paris); 1985 Dec 30; 33(10):951-6. PubMed ID: 3005949
    [Abstract] [Full Text] [Related]

  • 3. Abnormalities of in vitro immunoglobulin production in apparently healthy haemophiliacs: relationship with alterations of T cell subsets and with HTLV-III seropositivity.
    Biagiotti R, Giudizi MG, Almerigogna F, Mazzetti M, Alessi A, Del Prete GF, Rafanelli D, Fiorilli M, Morfini M, Romagnani S.
    Clin Exp Immunol; 1986 Feb 30; 63(2):354-8. PubMed ID: 3009063
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HTLV-III status and abnormalities in T lymphocyte distribution in children with hemophilia A.
    Shannon BT, Roach J, Cheek-Luten M, Ruymann FB.
    Diagn Immunol; 1986 Feb 30; 4(1):37-42. PubMed ID: 3006971
    [Abstract] [Full Text] [Related]

  • 6. Prevalence of HTLV-III/LAV antibodies in Italian asymptomatic hemophiliacs given commercial concentrates of factors VIII and IX.
    Verani P, Mariani G, Mannucci PM, De Rossi G, Nicoletti L, Titti F, Falcione E, Pasqualetti D, Ammassari M, Gringeri A.
    J Med Virol; 1986 Jun 30; 19(2):143-9. PubMed ID: 3014059
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Human T-lymphotropic retrovirus type III/lymphadenopathy-associated virus antibody. Association with hemophiliacs' immune status and blood component usage.
    Jason J, McDougal JS, Holman RC, Stein SF, Lawrence DN, Nicholson JK, Dixon G, Doxey M, Evatt BL.
    JAMA; 1985 Jun 21; 253(23):3409-15. PubMed ID: 2987559
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [HTLV-III antibodies and immunologic changes in hemophilic children. Prevalence of HTLV-III antibodies in hemophilic children and their relatives living in the same household].
    Zenz W, Muntean W, Teubl I, Beaufort F, Heinz FX.
    Padiatr Padol; 1987 Jun 21; 22(1):33-41. PubMed ID: 3108827
    [Abstract] [Full Text] [Related]

  • 11. Humoral and cellular immune abnormalities in adult hemophiliacs followed over a 2-year period.
    Freedman J, Mazaheri R, Read S, Garvey MB, Teitel J.
    Diagn Clin Immunol; 1987 Jun 21; 5(1):30-40. PubMed ID: 2439226
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. HTLV-I antibody status in hemophilia patients treated with factor concentrates prepared from U.S. plasma sources and in hemophilia patients with AIDS.
    Chorba TL, Jason JM, Ramsey RB, Lechner K, Pabinger-Fasching I, Kalyanaraman VS, McDougal JS, Cabradilla CD, Tregillus LC, Lawrence DN.
    Thromb Haemost; 1985 Apr 22; 53(2):180-2. PubMed ID: 2992112
    [Abstract] [Full Text] [Related]

  • 14. HTLV-III seropositivity in European haemophiliacs exposed to Factor VIII concentrate imported from the USA.
    Melbye M, Froebel KS, Madhok R, Biggar RJ, Sarin PS, Stenbjerg S, Lowe GD, Forbes CD, Goedert JJ, Gallo RC.
    Lancet; 1984 Dec 22; 2(8417-8418):1444-6. PubMed ID: 6151053
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The course of preexistent immune abnormalities in HIV negative haemophiliacs treated for two years with a monoclonal purified factor VIII concentrate.
    Smid WM, van der Meer J, Smit JW, Halie MR.
    Thromb Haemost; 1993 Apr 01; 69(4):306-10. PubMed ID: 8388579
    [Abstract] [Full Text] [Related]

  • 18. Clinical, immunological, and virological aspects in Japanese hemophiliacs and AIDS patients.
    Abe T.
    AIDS Res; 1986 Dec 01; 2 Suppl 1():S141-6. PubMed ID: 3103637
    [Abstract] [Full Text] [Related]

  • 19. Antibodies against HTLV-III in Danish haemophiliacs: relation to source of factor VIII used in treatment and immunological parameters.
    Lindhardt BO, Gerstoft J, Ulrich K, Bentzen K, Scheibel E, Dalsgård Nielsen J, Dickmeiss E.
    Scand J Haematol; 1985 Oct 01; 35(4):379-85. PubMed ID: 3001927
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.